Literature DB >> 1804491

Neural control of human nasal secretion.

J N Baraniuk1.   

Abstract

Patients with allergic and non-allergic nasal disorders may complain of symptoms of itching, discharge, congestion or fullness, and obstruction of airflow. The actions of sensory nerves and parasympathetic reflexes are central to the development of these symptoms, and likely play crucial roles in allergic and non-allergic nasal pathology. Nasal provocation studies have provided much information about the nature of the processes which contribute to the production of nasal secretions and the development of obstruction to nasal air flow. The results of human nasal provocation studies will be discussed after a review of the special anatomy of the human nasal mucosa, its vasculature, and its innervation.

Entities:  

Mesh:

Year:  1991        PMID: 1804491     DOI: 10.1016/0952-0600(91)90035-2

Source DB:  PubMed          Journal:  Pulm Pharmacol        ISSN: 0952-0600


  5 in total

1.  No acute effects of an exposure to 50 ppm acetaldehyde on the upper airways.

Authors:  A Muttray; J Gosepath; J Brieger; A Faldum; A Pribisz; O Mayer-Popken; D Jung; B Rossbach; W Mann; S Letzel
Journal:  Int Arch Occup Environ Health       Date:  2008-08-21       Impact factor: 3.015

2.  The intranasal Schirmer test: a preliminary study to quantify nasal secretion.

Authors:  Joerg Lindemann; Evangelia Tsakiropoulou; Gerhard Rettinger; Caroline Gutter; Marc Oliver Scheithauer; Valerie Picavet; Fabian Sommer
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-17       Impact factor: 2.503

Review 3.  Neurology of allergic inflammation and rhinitis.

Authors:  Brendan J Canning
Journal:  Curr Allergy Asthma Rep       Date:  2002-05       Impact factor: 4.806

Review 4.  Rhinitis as a mechanism of respiratory defense.

Authors:  R Eccles
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

5.  Ruthenium red antagonism of capsaicin-induced vascular changes in the rat nasal mucosa.

Authors:  F Bari; G Jancsó
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.